NCT07933640
A Clinical Study on Vagus Nerve Blockade at the Gastroesophageal Junction Combined With Tegileridine in the Very Early Postoperative Recovery Following Bariatric Surgery
StatusNot Yet Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Visual analogue scale (VAS) Score
Timeframe: postoperative 0, 2, 6, 12, and 24 hours
Secondary (7)
Quality-of-Recovery 15 (QoR-15) Score
Incidence of postoperative respiratory depression
Rescue analgesia rate
Total dose of sufentanil for rescue analgesia
Time of first ambulation
Show 2 moreShow less
Total Hospital Stay
Adverse effects
Arms and interventions
The control groupActive comparator
Bilateral transverse abdominal plane block and intravenous administration of Tegileridine
The experimental groupExperimental
Bilateral transverse abdominal plane block and intravenous administration of Tegileridine combined with the vagus nerve block at the gastroesophageal junction
Procedures: Bilateral transverse abdominal plane block and intravenous administration of Tegileridine combined with the vagus nerve block at the gastroesophageal junction, Bilateral Transversus Abdominis Plane Block (TAPB) and Intravenous infusion of Tegileridine.